Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal mucus layer and epithelial glycocalyx constitute a multi-layered physicochemical barrier that separates the luminal contents from the underlying intestinal epithelium. The mucus layer, primarily composed of the gel-forming mucin MUC2, acts as a sieve and lubricant, while the glycocalyx is a dense network of membrane-bound mucins and carbohydrates that provides a final protective shield and facilitates cell signaling (Johansson et al., 2011, PubMed: 21423175; Pelaseyed et al., 2014, PubMed: 24741103). This system is crucial for maintaining gut homeostasis by preventing the translocation of commensal and pathogenic bacteria while allowing for the absorption of nutrients (McGuckin et al., 2011, PubMed: 21386865). Dysregulation of this barrier, characterized by thinning or altered glycosylation, is a hallmark of inflammatory bowel diseases and can facilitate the development of colorectal cancer (Schoultz & Keita, 2020, PubMed: 32455582). Therapeutic strategies targeting this interface include mucoadhesive drug delivery systems to increase local drug concentration and agents designed to restore or reinforce the barrier's integrity (Cone, 2009, PubMed: 19133304).
Mucoadhesion to increase drug residence time, mucolysis to reduce viscosity for drug penetration, and barrier reinforcement to prevent pathogen translocation (Cone, 2009, PubMed: 19133304; Schoultz & Keita, 2020, PubMed: 32455582).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal mucus layer and epithelial glycocalyx.